ROMA; RISK OF OVARIAN MALIGNANCY ALGORITHM

Parameters: Single Component

Blood Test

4,500.00

ROMA is a qualitative serum test that derives a numerical score from the results of CA-125 (the most widely accepted biomarker for ovarian cancer) and HE4 blood tests, plus menopausal status, to identify patients presenting with an adnexal mass as being at high or low likelihood for having malignancy.

Specimen Type: Serum

Methodology: CMIA

Preparation: Provide Menopausal Status Of The Patient.

Delivery Time: Report Same Day

Test Code: Marker 03

Category: Tests Tag: CMIA

Preferred Date of Sample Collection *
Preferred Timeof Sample Collection *

ROMA; RISK OF OVARIAN MALIGNANCY ALGORITHM

Related Tests

Login